Clinical counterpoint: Vitamin D: New actions, new analogs, new therapeutic potential

Endocrine Reviews

Volumn 13, Issue 4, 1992, Pages 765-784

  Bikle, Daniel D ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D; VITAMIN D DERIVATIVE; 24,25 DIHYDROXYCOLECALCIFEROL; CALCITRIOL DERIVATIVE; DIHYDROTACHYSTEROL; DRUG ANALOG; VITAMIN; VITAMIN RECEPTOR;

BINDING AFFINITY; CANCER; DIABETES MELLITUS; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; DRUG STRUCTURE; HYPERTENSION; IMMUNE RESPONSE; METABOLIC BONE DISEASE; PRIORITY JOURNAL; PSORIASIS; REVIEW; STRUCTURE ACTIVITY RELATION; VITAMIN METABOLISM; ALBERS SCHOENBERG DISEASE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CHRONIC KIDNEY FAILURE; HUMAN; HYPERPARATHYROIDISM; IMMUNOPATHOLOGY; NONHUMAN; OSTEOPOROSIS; RICKETS;

NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER;

ANIMAL; BONE DISEASES; CALCITRIOL; DIABETES MELLITUS; HUMAN; HYPERTENSION; IMMUNITY; NEOPLASMS; PSORIASIS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; VITAMIN D;

EID: 0027093335     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/edrv-13-4-765     Document Type: Article

References (261)

1. 3 analogs. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D: Gene Regulation, Structure-Function Analysis and Clinical Application. Walter de Gruyter, New York, vol 1:146
2. Walters MR 1992 Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:000
3. Procsal DA, Okamura WH, Norman AW 1976 Vitamin D, its metabolites and analogs: a review of the structural requirements for biological activity. Am J Clin Nutr 29:1271
4. DeLuca HF, Schnoes HK 1976 Metabolism and mechanism of action of vitamin D. Annu Rev Biochem 45:631
5. Haddad Jr JG 1979 Transport of vitamin D metabolites. Clin Orthop 142:249
6. 3. Biochem Biophys Res Commun 65:24
7. 3 in target tissues. J Biol Chem 247:91
8. Procsal DA, Henry HL, Friedlander EJ, Norman AW 1977 Studies on the mode of action of calciferol. Arch Biochem Biophys 179:229
9. 3: a study of analog binding. Arch Biochem Biophys 179:462
10. 3 binding protein: specificity of binding. Steroids 30:245
11. Norman AW, Roth J, Orci L 1982 The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev 3:331
12. Lam H-Y, Schnoes HK, DeLuca HF 1975 Synthesis and biological activity of 25, 26-dihydroxycholecalciferol. Steroids 25:247
13. Bouillon R, Allewaert K, Xiang DZ, Tan BK, Baelen HV 1991 Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity. J Bone Miner Res 6:1051
14. Tanaka H, Hruska KA, Seino Y, Malone JD, Nishii Y, Teitelbaum SL 1991 Disassociation of the macrophage-maturational effects of vitamin D from respiratory burst priming. J Biol Chem 266:10888
15. Dusso AS, Negrea L, Gunawardhana S, Lopez-Hilker S, Finch J, Mori T, Nishii Y, Slatopolsky E, Brown AJ 1991 On the mechanisms for the selective action of vitamin D analogs. Endocrinology 128:1687
16. 3 in rat osteosarcoma cells: structure-function studies using ligand analogs. Endocrinology 129:1876
17. 3 receptor binding, 24-hydroxylase activity and in vitro bone resorption. Bone Miner 14:103
18. Pernalete N, Mori T, Nishii Y, Slatopolsky E, Brown AJ 1991 The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells. Endocrinology 129:778
19. 3. J Bone Miner Res 6:1307
20. 3 for 1, 25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells. Biochem Biophys Res Commun 169:629
21. 3 analogs: potencies on in vitro bone resorption differ from those reported for cell differentiation. J Bone Miner Res 5:201
22. 3 compounds: separation of calcium and cell differentiation activities. Biochemistry 29:190
23. 3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res 50:6857
24. 3 on alkaline phosphatase activity, osteocalcin and DNA synthesis by human osteoblastic cells in culture. Bone 11:171
25. Zhou JY, Norman AW, Lubbert M, Collins ED, Uskokovic MR, Koeffler HP 1989 Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization. Blood 74:82
26. Binderup L, Bramm E 1988 Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37:889
27. 3: preferential activity inducing differentiation of human leukemia cells HL-60 in vitro. Proc Natl Acad Sci USA 84:2610
28. 3, is a potent modulator of in vitro immunoregulating activity without inducing hypercalcemia in mice. Endocrinology 124:2645
29. Brown AJ, Ritter CR, Finch JL, Morrissey J, Martin KJ, Murayama E, Nishii Y, Slatopolsky E 1989 The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J Clin Invest 84:728
30. 3 with an oxygen atom in the side chain skeleton. FEBS Lett 226:58
31. 3 analogues with hydroxylated side chains, multi-homologated in the 24or 24, 26, 27-positions. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D. Gene Regulation Structure-Function Analysis and Clinical Application. Walter de Gruyter, New York, vol 1:159
32. 3 having potent differentiation-inducing activity without inducing hypercalcemia in vivo and in vitro. In: Norman AW, Schaefer K, Grigoleit H-G, Herrath DV (eds) Vitamin D. Molecular, Cellular and Clinical Endocrinology. Walter de Gruyter, New York, vol 1:310
33. Ostrem VK, Lau WF, Lee SH, Perlman K, Prahl J, DeLuca HF 1987 Induction of monocytic differentiation of HL-60 cells by dihydroxyvitamin D analogs. J Biol Chem 262:14164
34. Kabakoff BD, Kendrick NC, Faber D, DeLuca HF, Yamada S, Takayama H 1982 Determination of biological activity of 24, 24difluoro-l, 25-dihydroxyvitamin D3 in the chick using a new method for assessing intestinal calcium uptake. Arch Biochem Biophys 215:582
35. 3. Am J Physiol 244:E159
36. 3, and 1 alpha, 25-dihydroxyvitamin D326, 23-lactone in inducing differentiation of human myeloid leukemia cells. Arch Biochem Biophys 220:90
37. 3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 282:164
38. Uskokovic MR, Baggiolini E, Shiuey S-J, Iacobelli J, Hennessy B, Kiegiel J, Daniewski AR, Pizzolato G, Courtney LF, Horst RL 1991 The 16-ene analogs of 1, 25-dihydroxycholecalciferol. Synthesis and biological activity. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D. Gene Regulation, Structure-Function Analysis and Clinical Application. Walter de Gruyter, New York, vol 1:139
39. 3 [ED-71]. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D. Gene Regulation, Structure-Function Analysis and Clinical Application. Walter de Gruyter, New York, vol 1:289
40. Bikle D, Gee E 1988 Free and not total 1, 25-dihydroxyvitamin D regulates 25 hydroxyvitamin D metabolism by keratinocytes. Endocrinology 124:649
41. 3 mediated calcium transport from de novo RNA and protein synthesis. J Biol Chem 253:484
42. 3. Proc Natl Acad Sci USA 79:7939
43. Silver J, Russell J, Sherwood LM 1985 Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone gene transcription in vivo in the rat. Proc Natl Acad Sci USA 82:4270
44. 3 suppresses PTH secretion from bovine parathyroid cells in tissue culture. Endocrinology 117:2114
45. Bikle DD, Munson S 1985 1, 25-Dihydroxyvitamin D increases calmodulin binding to specific proteins in the chick duodenal brush border membrane. J Clin Invest 76:2312
46. 3 administration on calcium transport in chick intestine brush border membrane vesicles. J Biol Chem 254:2993
47. 3. Endocrinology 115:1476
48. 3 on the phosphoinositide metabolism in rat enterocytes. J Biol Chem 264:204-03
49. Baran DT, Milne ML 1986 1, 25-Dihydroxyvitamin D increases hepatocyte cytosolic calcium levels: a potential regulator of vitamin D-25-hydroxylase. J Clin Invest 77:1622
50. Civitelli R, Kim YS, Gunsten SL, Fujimori A, Huskey M, Avioli LV, Hruska KA 1990 Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells. Endocrinology 127:2253
51. 3 increased calcium and phosphatidylinositol metabolism in differentiating cultured human keratinocytes. J Nutr Biochem 1:81
52. Chen TL, Hirst MA, Feldman D 1979 A receptor-like binding macromolecule for la, 25-dihydroxycholecalciferol in cultured mouse bone cells. J Biol Chem 254:7491
53. Raisz LG, Maina DM, Gworek SG, Dietrich JW, Canalis EM 1978 Hormonal control of bone collagen synthesis in vitro: inhibitory effect of 1-hydroxylated vitamin D metabolites. Endocrinology 29:201
54. Wong GL, Luben RA, Cohn DV 1977 1, 25-dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells. Science 197:663
55. 3. J Biol Chem 257:8009
56. Canalis E 1983 Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae. Metabolism 32:14
57. 3 in human osteosarcoma (ROS 17/2.8) osteoblastic cells. J Bone Miner Res 1:441
58. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB 1991 Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128:1496
59. Underwood JL, DeLuca HF 1984 Vitamin D is not directly necessary for bone growth and mineralization. Am J Physiol 246:E493
60. Balsan S, Garabedian M, Larchet M, Groski A, Cournot G, Tau C, Bourdeau A, Silve C, Ricour C 1986 Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1, 25-dihydroxyvitamin D. J Clin Invest 77:1661
61. Bliziotes M, Yergey AL, Nanes MS, Muenzer J, Begley MG, Vieira NE, Kher KK, Brandi ML Marx SJ 1988 Absent intestinal response to calciferols in hereditary resistance to 1, 25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions. J Clin Endocrinol Metab 66:294
62. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 80:425
63. Suda T, Takahashi N Martin TJ 1992 Modulation of osteoclast differentiation. Endocr Rev 13:66
64. Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH 1988 Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 84:401
65. Ott SM, Chestnut CH 1989 Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 110:267
66. Gallagher JC, Goldgar D 1990 Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann Intern Med 113:649
67. Tilyard MW, Spears GFS, Thomson J, Dovey S 1992 Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357
68. Caniggia A, Nuti R, Lore F, Martini G, Turchetti V, Righi G 1990 Long-term treatment with calcitriol in postmenopausal osteoporosis. Metabolism 39 [Suppl 1]:43
69. 3. Bone Miner 3:47
70. Fujita T 1990 Studies in osteoporosis in Japan. Metabolism 39:39
71. Marks SC 1987 Osteopetrosis-multiple pathways for the interruption of osteoclast functions. Appl Pathol 5:172
72. Yoshida H, Hayashi SI, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa SI 1990 The murine mutation osteopetrosis in the coding region of the macrophage colony stimulating factor gene. Nature 345:442
73. Fischer A, Griscelli C, Friedrich W, Kubanek B, Levinsky R, Morgan G, Vossen J, Wagemaker G 1986 Bone marrow transplantation for immunodeficiencies and osteopetrosis: European survey 1968-1985. Lancet 2:1080
74. Cournot G, Trubert-Thil CL, Petrovic M, Boyle A, Cormier C, Girault D, Fischer A, Garabedian M 1992 Mineral metabolism in infants with malignant osteopetrosis: heterogeneity in plasma dihydroxyvitamin D levels and bone histology. J Bone Miner Res 7:1
75. Key L, Carnes D, Cole S, Holtrop M, Bar-Shavit Z, Shapiro F, Arceci R, Steinberg J, Gundberg C, Kahn A, Teitelbaum S, Anast C 1984 Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl J Med 310:409
76. Slatopolsky E, Lopez-Hilker S, Delmez J, Dusso A, Brown A, Martin KJ 1990 The parathyroid-calcitriol axis in health and chronic renal failure. Kidney Int 29:S41
77. 3 in chick parathyroid glands. Proc Natl Acad Sci USA 72:4871
78. 3 in chick parathyroid glands. Biochem Biophys Res Commun 62:781
79. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 316:1573
80. 3 receptors in experimental uremia. Kidney Int 32:350
81. Brown EM, Wilkson RE, Eastman RC, Pallotta J, Marynick SP 1982 Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab 54:172
82. 3 of transcription of the parathyroid hormone gene. Endocrinology 119:2864
83. 3. J Biol Chem 263:2203
84. ++ and the regulation of hormone secretion in parathyroid cells. In: Cohn DV, Martin TJ, Meunier PJ (eds) Calcium Regulation and Bone Metabolism. Elsevier Science, Basel, vol 1:167
85. Yamamoto M, Igarashi T, Muramatsu M, Fukagaw EM, Motokura T, Ogata E 1989 Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat. J Clin Invest 83:1053
86. Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB 1988 Hyperparathyroidism and 1, 25-dihydroxyvitamin D deficiency in mild, moderate and severe renal failure. J Clin Endocrinol Metab 67:876
87. 3 administration on bone in patients with renal failure. Kidney Int 38:S48
88. Coburn JW 1990 Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy. Kidney Int 38:S54
89. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ 1984 Marked suppression of secondary hyperparathyroidism by intravenous administration of 1, 25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136
90. Andress DL, Norris KC, Coburn JW, Slatopolsky E, Sherrard DJ 1989 Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274
91. Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E 1982 Parathyroid hormone suppression by intravenous dihydroxyvitamin D. J Clin Invest 83:1349
92. Dunlay R, Rodriguez M, Felsenfeld AJ, Llach F 1989 Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int 36:1093
93. Lyles KW, Drezner MK 1982 Parathyroid hormone effects on serum 1, 25-dihydroxyvitamin D levels in patients with x-linked hypophosphatémie rickets: evidence for abnormal 25-hydroxyvitamin D-l-hydroxylase activity. J Clin Endocrinol Metab 54:638
94. Insogna KL, Broadus AE, Gertner JM 1983 Impaired phosphorus conservation and 1, 25-dihydroxyvitamin D generation during phosphorus depletion in familial hyposphophatemic rickets. J Clin Invest 71:1562
95. Scriver CR, Reade TM, DeLuca HF, Hamstra AJ 1978 Serum dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N Engl J Med 299:976
96. Delvin EE, Glorieux FH 1981 Serum 1, 25-dihydroxyvitamin D concentrations in hypophosphatémie vitamin D-resistant rickets. Calcif Tissue Int 33:173
97. Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL 1983 Long-term influence of calcitriol (1, 25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatémie rickets. Pediatrics 71:559
98. Glorieux FH, Marie PJ, Pettifor JM, Delvin EE 1980 Bone response to phosphate salts, ergocalciferol and calcitriol in hypophosphatémie vitamin D-resistant rickets. N Engl J Med 303:1023
99. Patron P, Gardin J-P, Borensztein P, Prigent A, Paillard M 1989 Marked direct suppression of primary hyperparathyroidism with osteitis fibrosa cystica by intravenous administration of 1, 25dihydroxycholecalciferol. Miner Electrolyte Metab 15:321
100. Garland CF, Garland FC, Gorham ED 1991 Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr 54:193S
101. Garland FC, Garland CF, Gorham ED, Young JF 1990 Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19:614
102. Garland CF, Shekelle RB, Barrett-Connor E 1985 Dietary calcium and vitamin D and risk of colorectal cancer: a 19-year old prospective study in men. Lancet 1:307
103. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED 1989 Serum 25-dihydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2:1176
104. Slatter ML, Sorenson AW, Ford MH 1988 Dietary calcium intake as a mitigating factor in colon cancer. Am J Epidermiol 128:504
105. Stemmermann GN, Nomura A, Chyou PH 1990 The influence of dairy and nondairy calcium on subsite large-bowel cancer risk. Dis Colon Rectum 33:190
106. Kune S, Kune GA, Watson LF 1987 Case-control study of dietary etiological factors: the Melbourne colorectal cancer study. Nutr Cancer 9:21
107. Simard A, Vobecky J, Vobecky JS 1991 Vitamin D deficiency and cancer of the breast: an unprovocative ecological hypothesis. Can J Public Health 82:300
108. Schwartz GG, Hulka BS 1990 Is vitamin D deficiency a risk factor for prostate cancer? (hypothesis). Anticancer Res 10:1307
109. 3 suppresses the in vivo growth of human cancer solid tumor xenografts. Cancer Res 47:21
110. Manolagas SC 1987 Vitamin D and its relevance to cancer. Anticancer Res 7:625
111. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108:1083
112. 3 metabolites. Cancer Res 43:4443
113. 3. Proc Natl Acad Sci USA 78:4990
114. 3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 102:937
115. Dodd RC, Cohen MS, Newman SL, Gray TK 1983 Vitamin D metabolites change the phenotype of monoblastic U-937 cells. Proc Natl Acad Sci USA 80:7538
116. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol 98:391
117. Olsson I, Gulberg U, Ivied I, Nilsson K 1983 Induction of differentiation of the human histiocytic lymphoma cell line U-937 by dihydroxycholecalciferol. Cancer Res 43:5862
118. 3 and its analogues. Cancer Res 44:5624
119. 3 induces maturation of the human monocyte cell line U937, and, in association with a factor from T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest 73:731
120. Bikle DD, Pillai S, Gee E 1992 Squamous carcinoma cell lines produce 1, 25-dihydroxyvitamin D but fail to respond to its prodifferentiating effect. J Invest Dermatol 97:435
121. 3. Carcinogenesis 9:187
122. Kawaura A, Tanida N, Sawada K 1989 Supplemental administration of la-hydroxyvitamin D inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats. Carcinogenesis 10:647
123. 3. Cancer Res 45:5426
124. 3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin. Biochem Biophys Res Commun 116:605
125. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 80:201
126. 3. Cancer Res 47:21
127. Colston KW, Berger U, Coombes RC 1989 Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1:188
128. 3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer 62:1399
129. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129:832
130. 3 prolongs survival time of leukemic mice. Proc Natl Acad Sci USA 87:3929
131. Breslau NA, McGuire JL, Zerwekh JE, Frankel EP, Pak CYC Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med 100:1
132. Mudde AH, van den Berg H, Boshuis PG 1987 Ectopic production of 1, 25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia. Cancer 59:1543
133. Needle MA, Chandra B 1984 Hypercalcemia, Hodgkin’s disease and calcitriol. Ann Intern Med 100:916
134. Zaloga GP, Eil C, Medbery CA 1985 Humoral hypercalcemia in Hodgkin’s disease. Association with elevated 1, 25-dihydroxycholecalciferol levels and subperiosteal bone reabsorption. Arch Intern Med 145:155
135. Davies M, Hayes ME, Mawer EB, Lumb GA 1985 Abnormal vitamin D metabolism in Hodgkin’s lymphoma. Lancet 1:1186
136. Rosenthal N, Insogna KL, Godsall JW, Smaldone L, Waldron JA, Stewart AF 1985 Elevations in circulating 1, 25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 60:29
137. 3 in a patient with Hodgkin’s lymphoma. Klin Wochenschr 64:89
138. Rieke JW, Donaldson SS, Horning SJ 1989 Hypercalcemia and vitamin D metabolism in Hodgkin’s disease. Cancer 63:1700
139. Mercier RJ, Thompson JM, Messerschmidt GL 1988 Recurrent hypercalcemia and elevated 1, 25-dihydroxyvitamin D levels in Hodgkin’s disease. Am J Med 84:165
140. Lambrecht L, Boelaert J, Louwagie A, Criel A, Daniels R, Bouillar R 1986 Hypercalcemia in Hodgkin’s disease. Acta Clin Belg 1:37
141. 3 by human T-cell lymphotrophic virus-1-transformed lymphocytes. J Clin Invest 78:592
142. 3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57:1308
143. 3 receptors in human leukocytes. Science 221:181
144. 3: specific inhibition at the level of messenger RNA. J Clin Invest 79:1659
145. 3 inhibits r-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 84:3385
146. 3 in human peripheral blood lymphocytes. J Clin Invest 79:1700
147. 3 on human lymphocytes and monocytes/macrophage: inhibition of interleukin 2 and augmentation of interleukin 1 production. Cell Immunol 98:311
148. 3. Kidney Int 29:S9
149. 3 metabolites and tumor necrosis factor in the pathogenesis of tuberculosis. Immunology 62:229
150. 2, interleukin 1, and tumor necrosis factor a by human monocytes. Bone 13:185
151. 3 activates secretion of hydrogen peroxide by human monocytes. J Immunol 136:1049
152. 3 maintains adherence of human monocytes and protects them from thermal injury. J Clin Invest 77:1332
153. 3 on in vitro immunoglobulin production by B cells. J Immunol 136:4427
154. 3 binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J Immunol 136:2734
155. 3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161:755
156. Koeffler HP, Reichel H, Bishop JE, Norman AW 1985 GammaInterferon stimulates production of 1, 25-dihydroxyvitamin. Biochem Biophys Res Commun 127:596
157. Mason RS, Frankel T, Chan YL, Lissner D, Posen S 1984 Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med 100:59
158. 3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 72:1856
159. 3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. Am Rev Respir Dis 138:984
160. Barnes PF, Modlin RL, Bikle DD, Adams JS 1989 Transpleural gradient of 1, 25-dihydroxyvitamin D in tuberculous pleuritis. J Clin Invest 83:1527
161. Stroder J, Kasai P 1970 Evaluation of phagocytosis in rickets. Acta Paediatr Scand 59:288
162. Lorente F, Fontan G, Jara P, Casas C, Garcia-Rodriguez MC, Ojeda JA 1976 Defective neutrophil motility in hypovitaminosis D rickets. Acta Paediatr Scand 65:695
163. Davies PDO 1985 A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle 66:301
164. Toss G, Symreng T 1983 Delayed hypersensitivity response and vitamin D deficiency. Int J Vitam Nutr Res 53:27
165. 3 on cell-mediated immunity in hemodialyzed patients. J Clin Endocrinol Metab 63:1218
166. Walka MM, Däumling S, Hadorn H-B, Kruse K, Belohradsky BH 1991 Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction. Eur J Pediatr 150:665
167. Etzioni A, Hochberg Z, Poliak S, Meshulam T, Zakut V, Tzehoval E, Keisari Y, Aviram I, Spirer Z, Benderly A, Weisman Y 1989 Defective leukocyte fungicidal activity in end-organ resistance to dihydroxyvitamin D. Pediatr Res 25:276
168. 3. Clin Immunol Immunopathol 53:24
169. 3: a pilot study. Arthritis Rheum 33:1723
170. Stroder J, Schneider J 1975 Immunity in vitamin D deficient rickets. In: Norman AW, Schaefer K, Herrath DV, Ritz E (eds) Vitamin D and Problems Related to Uremic Bone Disease. Walter de Gruyer, New York, vol 1:675
171. 3 and the regulation of macrophage function. Calcif Tissue Int 33:673
172. 3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87:1103
173. 3 administration on lymphoproliferation and autoimmune disease in MRL/MP-lpr/lpr mice. Int Arch Allergy Appl Immunol 77:396
174. 3 having a potent immunoregulating activity without inducing hypercalcemia in mice. J Bone Miner Res 4:S260
175. Erne P, Bolli P, Burgisser E, Buhler FR 1984 Correlation of platelet calcium with blood pressure, effect of antihypertensive therapy. N Engl J Med 310:1084
176. Kesteloot H, Geboers J 1982 Calcium and blood pressure. Lancet 1:813
177. Rosenthal FD, Roy S 1972 Hypertension of hyperparathyroidism. Br Med J 4:396
178. Hellstrom J, Birke G, Edvall CA 1958 Hypertension in hyperparathyroidism. Br J Urol 11:369
179. Sowers MFR, Wallace RB, Hollis BW, Lemke JH 1988 Relationships between 1, 25-dihydroxyvitamin D and blood pressure in a geographically defined population. Am J Clin Nutr 48:1053
180. Hulter HN, Melby JC, Peterson JC, Cooke CR 1986 Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 2:360
181. Collip JB, Clark EP 1925 Further studies on the physiological action for parathyroid hormone. J Biol Chem 64:485
182. Pang PKT, Tenner Jr TE, Yee JA 1980 Hypotensive action of parathyroid hormone preparations on rats and dogs. Proc Natl Acad Sci USA 77:675
183. Tresham JJ, McGuire P, Coghlan JP, Whitworth JA, Scoggins BA 1988 The effects of calcium and vitamin D on blood pressure in conscious sheep. Clin Exp Hypertens A10:1085
184. Berl T, Levi M, Ellis M, Chaimovitz C 1985 Mechanism of acute hypercalcemic hypertension in the conscious rat. Hypertension 7:923
185. Bianchetti MG, Beretta-Piccoli C, Weidmann P, Link L, Boehringer K, Ferrier C, Morton JJ 1983 Calcium and blood pressure regulation in normal and hypertensive subjects. Hypertension 5:57
186. Marone C, Beretta-Piccoli C, Weidmann P 1980 Acute hypercalcemic hypertension in man: role of haemodynamics, catecholamines and renin. Kidney Int 20:92
187. Weidmann P, Massry SG, Coburn JW, Maxwell MH, Atleson J, Leeman CR 1972 Blood pressure effect of acute hypercalcemia. Ann Intern Med 76:741
188. McCarron DA, Morris CD 1986 Metabolic considerations and cellular mechanism related to calcium’s antihypertensive effects. Fed Proc 45:2734
189. Grobee DE, Hofman A 1986 Effect of calcium supplementation on diastolic blood pressure in young people with mild hypertension. Lancet 2:703
190. Belizan JM, Villar J, Pineda O 1983 Reduction of blood pressure with calcium supplementation in young adults. JAMA 249:1161
191. McCarron DA, Morris CD 1985 Blood pressure response to oral calcium in persons with mild to moderate hypertension. Ann Intern Med 103:825
192. Lyle RM, Melby CL, Hyner GC, Edmondson JW, Miller JZ, Weinberger MH 1987 Blood pressure and metabolic effects of calcium supplementation in normotensive white and black males. JAMA 257:1772
193. Johnson NE, Smith EL, Freudenheim JL 1985 Effects on blood pressure of calcium supplementation of women. Am J Clin Nutr 42:12
194. Strazzullo P, Nunziata V, Cirillo M 1983 Abnormalities of calcium metabolism in essential hypertension. Clin Sci 65:137
195. McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch M, Krutzik S 1980 Enhanced parathyroid hormone function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 2:162
196. Schedl HP, Miller DL, Pape JM, Horst RL, Wilson HD 1984 Calcium and sodium transport and vitamin D metabolism in the spontaneously hypertensive rat. J Clin Invest 73:980
197. 2+ fluxes. J Clin Invest 76:1147
198. Lau K, Langman CB, Gafter U, Dudeja PK, Brasitus TA 1986 Increased calcium absorption in prehypertensive spontaneously hypertensive rat. J Clin Invest 78:1083
199. Resnick LM, Muller FB, Laragh JH 1986 Calcium regulating hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Ann Intern Med 105:649
200. Resnick LM, Nicholson JP, Laragh JH 1986 Calcium metabolism in essential hypertension: relationship to altered renin system activity. Fed Proc 45:2739
201. Nicholson JP, Resnick LM, Laragh JH 1987 The antihypertensive effect of verapamil at extremes of dietary sodium intake. Ann Intern Med 107:329
202. Postnov YV, Orlov SN, Pokudin NI 1979 Decrease in calcium binding by the red blood cell membrane in spontaneously hypertensive rats and in essential hypertension. Pfluegers Arch 379:191
203. Walters MR, Wicker DC, Riggle PC 1986 1, 25-Dihydroxyvitamin D receptors identified in the rat heart. J Mol Cell Cardiol 18:67
204. 3 receptors and actions in vascular smooth muscle. Calcif Tissue Int 41:1706
205. +2 uptake by cultured adult rat ventricular cardiac muscle cells. J Biol Chem 262:2536
206. Hochhäuser E, Barak J, Kushnir T, Navon G, Meyer MS, Edelstein S, Bassat MB, Vidne BA 1989 Mechanical, biochemical, and structural effects of vitamin D deficiency on the chick heart. Angiology 1:300
207. 3 and cardiovascular function in rats. J Clin Invest 79:1706
208. Baksi SN 1988 Altered pressor response to norepinephrine in calcium and vitamin D-deficient rats. Clin Exp Hypertens A10:811
209. Ljunghall S, Hvarfner A, Lind L 1987 Clinical studies of calcium metabolism in essential hypertension. Eur Heart J 8:37
210. 3 in chick kidney and pancreas. Biochem Biophys Res Commun 89:56
211. Morrissey RL, Bucci TJ, Empson RN, Lufkin EG 1975 Calcium binding protein: its cellular localization in jejunum, kidney and pancreas. Proc Soc Exp Biol Med 149:56
212. Arnold BB, Kuttner M, Willis DM, Hitchman JW, Harrison JE, Murray TM 1975 Radioimmunoassay studies of intestinal calcium binding protein in the pig. II. The distribution of intestinal CaBP in pig tissues. Can J Physiol Pharmacol 53:1135
213. 3 receptors in chick pancreas and kidney cytosol. Endocrinology 108:140
214. 3 in chick pancreas; a partial physical and functional characterization. J Steroid Biochem 16:385
215. 3 in the pancreas. Cell Tissue Res 209:515
216. Norman AW, Frankel BJ, Heldt AM, Grodsky GM 1980 Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209:823
217. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, DeLuca HF 1983 Cellular mechanisms of insulin release: the effects of vitamin deficiency and repletion on rat insulin secretion. Endocrinology 113:1511
218. 3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 119:84
219. Kadowaki S, Norman AW 1984 Dietary vitamin D is essential for normal insulin secretion from perfused rat pancreas. J Clin Invest 73:759
220. 3 on insulin secretion: direct or mediated? Endocrinology 118:1971
221. 3 enhances the effect of refeeding on steady state preproinsulin messenger ribonucleic acid levels in rats. Endocrinology 126:2041
222. Hochberg Z, Borochowitz Z, Benderli A, Vardi P, Oren S, Spirer Z, Heyman I, Weisman Y 1985 Does 1, 25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands? J Clin Endocrinol Metab 60:57
223. 3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 120:1490
224. 3-la-hydroxylase activity. Endocrinology 107:300
225. 3 production by isolated renal slices is modulated by diabetes and insulin in the rat. Diabetes 32:302
226. Mathiassen B, Sielsen S, Johansen JS, Hartwell D, Ditzel J, Christiansen C 1990 Long-term bone loss in insulin-dependent diabetic patients with microvascular complications. J Diabet Complications 4:145
227. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargmann GJ 1981 Osteopenia in juvenile diabetes. Calcif Tissue Int 33:455
228. Hui SL, Epstein S, Johnston CC 1985 A prospective study of bone mass in patients with type 1 diabetes. J Clin Endocrinol Metab 60:74
229. Levin M, Boisseau V, Avioli L 1976 Effects of diabetes mellitus on bone mass in juvenile and adult onset diabetes. N Engl J Med 294:241
230. Ihida H, Seino Y, Matsukura S, Ikeda M, Yawata M, Yamahita G, Ishizuka S, Imura H 1985 Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin independent) diabetes. Metabolism 34:797
231. Nyomba BL, Verhaeghe J, Thomasset M, Lissens W, Bouillon R 1989 Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. Endocrinology 124:565
232. Schneider LE, Schedl HP, McCain T, Haussier MR 1977 Experimental diabetes reduces circulating 1, 25-dihydroxyvitamin D in the rat. Science 196:1452
233. Hough S, Fausto A, Sonn Y, Don JK, Birge SJ, Avioli LV 1983 Vitamin D metabolism in the chronic streptozotocin-induced diabetic. Endocrinology 113:790
234. Schneider LE, Schedl HP 1972 Diabetes and intestinal calcium absorption in the rat. Am J Physiol 223:1319
235. Schneider LE, Wilson HD, Schedl HP 1973 Intestinal calcium binding protein in the diabetic rat. Nature 245:327
236. Goodman WG, Hori MT 1984 Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 33:825
237. Mak RHK 1989 Insulin secretion in uremia: effect of parathyroid hormone and vitamin D metabolites. Kidney Int 36:S227
238. Kuoppala T 1988 Alterations in vitamin D metabolites and minerals in diabetic pregnancy. Gynecol Obstet Invest 25:99
239. Frazer T, White N, Hough S, Santiago J, McGee B, Bryce G, Mallon J, Avioli L 1981 Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J Clin Endocrinol Metab 53:1154
240. Heath III H, Lambert P, Service F, Arnaud S 1979 Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab 49:462
241. Tsang R, Kleinman L, Sutherland J, Light I 1972 Hypocalcemia in infants of diabetic mothers. J Pediatr 80:384
242. Witt MF, White NH, Santiago JV, Seino Y, Avioli LV 1982 Increased calcium absorption in type I diabetic children (IDD). Pediatr Res 16:1129
243. Heath H, Melton JL, Chu-Pin C 1980 Diabetes mellitus and risk of skeletal fracture. N Engl J Med 303:567
244. Bouillon R 1991 Diabetic bone disease. Calcif Tissue Int 49:155
245. 3 production by human keratinocytes: kinetics and regulation. J Clin Invest 78:557
246. 3. Biochem Biophys Res Commun 25:1545
247. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 206:1188
248. 3. Endocrinology 113:1950
249. Pillai S, Bikle DD, Elias PM 1988 1, 25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 263:5390
250. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum free conditions. J Invest Dermatol 86:709
251. 3. J Cell Physiol 146:94
252. 3. J Invest Dermatol 86:709
253. 3 treatment in psoriasis. Br J Dermatol 115:431
254. 3-open-design study. Calcif Tissue Int 39:209
255. 3 analogue, la, 24-dihydroxycholecalciferol. Br J Dermatol 115:431
256. Henderson CA, Papworth-Smith J, Cunliffe WJ, Highet AS, Shamy HK, Czarnetzki BM 1989 A double-blind, placebo-controlled trial of topical 1, 25-dihydroxycholecalciferol in psoriasis. Br J Dermatol 121:493
257. 3 can be a safe and effective therapy for psoriasis. J Am Acad Dermatol 19:516
258. 3, MC 903, and their analogues herald a new pharmacologic era for the treatment of psoriasis. Arch Dermatol Res 125:1692
259. Adashi EY, Resnick CE, Vera A, Hernandez E 1991 In vivo regulation of granulosa cell type I insulin-like growth factor receptors: evidence for an inhibitory role for the putative endogenous ligand(s) of the ovarian gonadotropin-releasing hormone receptor. Endocrinology 128:3130
260. Staberg B, Roed-Petersen J, Menne T 1989 Efficacy of topical treatment in psoriasis with MC 903, a new vitamin D analogue. Acta Derm Venereol (Stockh) 69:147
261. Kragballe K, Gjertsen BT, DeHoop D, Karlsmark T, van De Kerkhof PCM, Larko O, Tikjob G, Nieboer C, Strand A, RoedPetersen J 1991 Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psorasis vulgaris. Lancet 337:193